Honoring Morgan Stanley: Advancing Medical Discoveries
Harrington Discovery Institute honors Morgan Stanley for their generous support and shared commitment to creating life-changing medicines. Through their annual client satisfaction survey, Morgan Stanley invites clients to select a charitable cause to support. We are thrilled to announce that this year’s initiative includes a donation to Harrington Discovery Institute at University Hospitals, helping fuel our mission to bring new treatments to patients in need.
A Transformative Partnership
Morgan Stanley GIFT Cures℠, established in 2019 in partnership with Harrington Discovery Institute, exemplifies the power of collaborative philanthropy. As the first special interest program of Morgan Stanley Global Impact Funding Trust (GIFT), it provides opportunities for new and veteran philanthropists to combine their resources to magnify the impact of their medically related giving. Donors can focus on a specific disease or support the development of new therapeutics across disease areas.
This unique collaboration combines philanthropy, pharma expertise, and strategic investing to accelerate the development of next-generation medicines.
“Our partnership with Morgan Stanley GIFT Cures reflects the tremendous potential of combining impact philanthropy with scientific innovation. Their commitment to advancing drug discovery and development is helping to advance new treatments for patients,” said Jonathan S. Stamler, MD, President and co-Founder of Harrington Discovery Institute.
We appreciate Morgan Stanley’s ongoing support and especially this year-end donation. Together, we are advancing a shared vision of accelerating the development of new medicines and improving human health around the world.
To learn more about this partnership, visit Morgan Stanley GIFT Cures.